A recent preclinical study published in Vaccines reported systemic and mucosal immunity against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) via intranasal delivery of a vaccine ...
Findings showed that the booster dose elicited robust antibody responses comparable to, or exceeding levels associated with the efficacy data in the primary series of the vaccine. The Food and Drug ...
The recent introduction of oil-in-water emulsions as adjuvants in several pandemic vaccines, such as the H1N1 vaccine, has challenged regulatory authorities to establish their safety in the general ...
While much of the global concern has subsided, COVID-19 is still a very real threat, especially to people with compromised immune systems or who are over 65. Vaccination offers excellent protection ...
The FDA has expanded the EUA for the Novavax COVID-19 Vaccine, Adjuvanted to include adolescents 12 to 17 years of age to prevent COVID-19. The Food and Drug Administration (FDA) has expanded the ...
An international team of scientists has observed that the immunity elicited by recombinant adjuvanted zoster vaccine (RZV) offers heterologous protection, reducing the risk of coronavirus disease 2019 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results